DEURUXOLITINIB PHOSPHATE

DEURUXOLITINIB PHOSPHATE was reported 174 times

DEURUXOLITINIB PHOSPHATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 IMPETIGO 1 0.0007
1 INFECTIOUS MONONUCLEOSIS 1 0.0004
2 THERAPEUTIC PRODUCT EFFECT DELAYED 2 0.0004
3 THERAPY CESSATION 15 0.0003
4 SUICIDAL BEHAVIOUR 1 0.0002
5 PRODUCT DISPENSING ISSUE 1 0.0002
6 INTENTIONAL DOSE OMISSION 6 0.0002
7 PRODUCT USE ISSUE 39 0.0002
8 STREPTOCOCCAL INFECTION 1 0.0002
9 HERPES VIRUS INFECTION 1 0.0002
10 METABOLIC DISORDER 1 0.0002
11 PLATELET COUNT INCREASED 2 0.0002
12 HAIR GROWTH ABNORMAL 1 0.0001
13 LIVER FUNCTION TEST INCREASED 3 0.0001
14 ARTHROPOD BITE 1 0.0001
15 ACNE 10 0.0001
16 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
17 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
18 HEAVY MENSTRUAL BLEEDING 1 0.0001
19 PHARYNGITIS STREPTOCOCCAL 1 0.0001
20 MADAROSIS 1 0.0001
21 THERAPY INTERRUPTED 6 0.0001
22 HAIR COLOUR CHANGES 1 0.0001
23 RESPIRATORY TRACT INFECTION 2 0.0001
24 ORAL CANDIDIASIS 1 0.0001
25 IMMUNE SYSTEM DISORDER 1 0.0001
26 HAIR TEXTURE ABNORMAL 1 0.0001
27 SINUS CONGESTION 1 0.0001
28 BLOOD TEST ABNORMAL 1 0.0001
29 PRODUCT DOSE OMISSION ISSUE 20 0.0001
30 INSURANCE ISSUE 1 0.0001
31 BLOOD CHOLESTEROL INCREASED 3 0.0001
32 THERAPY PARTIAL RESPONDER 1 0.0001
33 THERAPEUTIC RESPONSE DECREASED 3 0.0000
34 NEURALGIA 1 0.0000
35 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
36 EAR INFECTION 1 0.0000
37 TREATMENT NONCOMPLIANCE 2 0.0000
38 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
39 LABORATORY TEST ABNORMAL 1 0.0000
40 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
41 NASOPHARYNGITIS 6 0.0000
42 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
43 INFLUENZA 3 0.0000
44 WEIGHT INCREASED 6 0.0000
45 COLITIS 1 0.0000
46 LIVER DISORDER 1 0.0000
47 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
48 TINNITUS 1 0.0000
49 DRUG INEFFECTIVE 28 0.0000
50 DISEASE RECURRENCE 1 0.0000
51 CONDITION AGGRAVATED 6 0.0000
52 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
53 HERPES ZOSTER 1 0.0000
54 NASAL CONGESTION 1 0.0000
55 EXPOSURE DURING PREGNANCY 1 0.0000
56 DEHYDRATION 2 0.0000
57 FATIGUE 11 0.0000
58 HYPOAESTHESIA 2 0.0000
59 HOT FLUSH 1 0.0000
60 PARAESTHESIA 2 0.0000
61 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
62 DRY MOUTH 1 0.0000
63 PRODUCT STORAGE ERROR 1 0.0000
64 HEADACHE 7 0.0000
65 OROPHARYNGEAL PAIN 1 0.0000
66 HYPERSENSITIVITY 2 0.0000
67 COUGH 3 0.0000
68 PULMONARY EMBOLISM 1 0.0000
69 MIGRAINE 1 0.0000
70 DRUG INTOLERANCE 1 0.0000
71 ALOPECIA 2 0.0000
72 ABDOMINAL PAIN UPPER 2 0.0000
73 ABDOMINAL DISTENSION 1 0.0000
74 CHILLS 1 0.0000
75 JOINT SWELLING 1 0.0000
76 PRURITUS 3 0.0000
77 MALAISE 3 0.0000
78 BLOOD PRESSURE INCREASED 1 0.0000
79 CEREBROVASCULAR ACCIDENT 1 0.0000
80 MYALGIA 1 0.0000
81 COVID-19 1 0.0000
82 ANAEMIA 1 0.0000
83 GAIT DISTURBANCE 1 0.0000
84 HYPOTENSION 1 0.0000
85 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
86 ARTHRALGIA 2 0.0000
87 HYPERTENSION 1 0.0000
88 DEPRESSION 1 0.0000
89 DECREASED APPETITE 1 0.0000
90 FEELING ABNORMAL 1 0.0000
91 INSOMNIA 1 0.0000
92 OFF LABEL USE 3 0.0000
93 DIARRHOEA 1 0.0000
94 NAUSEA 1 0.0000
95 DEATH 1 0.0000